| 1 | Lung non-small cell carcinoma | Enrichment | BRAF, EGFR, ERBB2, HRAS, MAP2K1, PIK3CA | 8.41 |
| 2 | Junctional epidermolysis bullosa | Enrichment | ITGA6, ITGB4, LAMA3, LAMB3, LAMC2 | 7.12 |
| 3 | Epidermolysis bullosa, junctional 1a, intermediate | Enrichment | ITGB4, LAMA3, LAMB3, LAMC2 | 6.19 |
| 4 | Junctional epidermolysis bullosa non-herlitz type | Enrichment | ITGB4, LAMA3, LAMB3, LAMC2 | 6.19 |
| 5 | Noonan syndrome 1 | Enrichment | BRAF, HRAS, MAP2K1, PPP1CB, RAF1, SOS1 | 6.13 |
| 6 | Rasopathy | Enrichment | BRAF, HRAS, MAP2K1, PPP1CB, RAF1, SOS1 | 5.79 |
| 7 | Noonan syndrome and noonan-related syndrome | Enrichment | BRAF, HRAS, MAP2K1, RAF1, SOS1 | 5.77 |
| 8 | Bladder cancer | Enrichment | CTNNB1, EGFR, ERBB2, HRAS, PIK3CA, PTEN | 5.49 |
| 9 | Colorectal cancer | Enrichment | AKT1, BRAF, CCND1, CTNNB1, ERBB2, MET, PIK3CA, PIK3R1, SRC | 5.32 |
| 10 | Ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL5A2, THBS2, TNXB | 5.21 |
| 11 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | AKT3, PIK3CA, PIK3R2 | 4.92 |
| 12 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 | Enrichment | AKT3, CCND2, PIK3R2 | 4.92 |
| 13 | Meningioma | Enrichment | AKT1, PDGFB, PIK3CA, PTEN | 4.70 |
| 14 | Lip and oral cavity carcinoma | Enrichment | BRAF, EGFR, HRAS, PIK3CA | 4.70 |
| 15 | Hemimegalencephaly | Enrichment | AKT3, PIK3CA, PTEN | 4.52 |
| 16 | Ehlers-danlos syndrome, classic type, 1 | Enrichment | COL1A1, COL1A2, COL5A2 | 4.23 |
| 17 | Cowden syndrome 1 | Enrichment | EGFR, PIK3CA, PTEN | 4.23 |
| 18 | Epidermolysis bullosa, junctional 1b, severe | Enrichment | LAMA3, LAMB3, LAMC2 | 4.23 |
| 19 | Keratoconus | Enrichment | COL1A1, COL4A1, COL5A2 | 4.23 |
| 20 | Fetomaternal alloimmune thrombocytopenia 1 | Enrichment | ITGA2, ITGA2B, ITGB3 | 4.23 |
| 21 | Classic ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL5A2 | 4.23 |
| 22 | Lung cancer | Enrichment | BRAF, EGFR, ERBB2, MET, PIK3CA | 4.04 |
| 23 | Thyroid cancer, nonmedullary, 2 | Enrichment | BRAF, HRAS, PTEN | 3.99 |
| 24 | Noonan syndrome 3 | Enrichment | HRAS, RAF1, SOS1 | 3.99 |
| 25 | Gallbladder cancer | Enrichment | BRAF, CTNNB1, PIK3CA | 3.99 |
| 26 | Follicular thyroid carcinoma | Enrichment | BRAF, HRAS, PTEN | 3.99 |
| 27 | Ovarian cancer | Enrichment | AKT1, CTNNB1, EGFR, ERBB2, MET, PDGFRA, PIK3CA, PTEN | 3.95 |
| 28 | Melanocytic nevus syndrome, congenital | Enrichment | BRAF, HRAS, RAF1 | 3.79 |
| 29 | Epiphyseal dysplasia, multiple, 1 | Enrichment | COL1A1, COMP | 3.67 |
| 30 | Spondyloepimetaphyseal dysplasia, strudwick type | Enrichment | COL2A1, FN1 | 3.67 |
| 31 | Spondylometaphyseal dysplasia, corner fracture type | Enrichment | COL2A1, FN1 | 3.67 |
| 32 | Dermatofibrosarcoma protuberans | Enrichment | COL1A1, PDGFB | 3.67 |
| 33 | Pulmonic stenosis | Enrichment | BRAF, SOS1 | 3.67 |
| 34 | Ehlers-danlos syndrome, arthrochalasia type, 2 | Enrichment | COL1A1, COL1A2 | 3.67 |
| 35 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1, MET | 3.67 |
| 36 | Immune system disease | Enrichment | CDC42, PIK3CD | 3.67 |
| 37 | Baraitser-winter cerebrofrontofacial syndrome | Enrichment | ACTB, ACTG1 | 3.67 |
| 38 | Ehlers-danlos/osteogenesis imperfecta syndrome | Enrichment | COL1A1, COL1A2 | 3.67 |
| 39 | Arteriovenous malformation | Enrichment | HRAS, MAP2K1, PIK3CA | 3.62 |
| 40 | Adult hepatocellular carcinoma | Enrichment | CTNNB1, EGF, PIK3CA | 3.62 |
| 41 | Cowden syndrome | Enrichment | AKT1, PIK3CA, PTEN | 3.62 |
| 42 | Myopathy, x-linked, with excessive autophagy | Enrichment | HRAS, MAP2K1, PIK3CA | 3.47 |
| 43 | Autosomal dominant macrothrombocytopenia | Enrichment | ACTN1, ITGA2B, ITGB3 | 3.47 |
| 44 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | CAV3, FLNC, MYLK2, RAF1 | 3.43 |
| 45 | Nephrotic syndrome | Enrichment | COL4A4, FN1, ITGA3, LAMA5, LAMB2 | 3.41 |
| 46 | Microcephaly | Enrichment | ACTB, ACTG1, COL4A1, CTNNB1, DIAPH1, IGF1R, MAPK1, PAK3 | 3.36 |
| 47 | Bleeding disorder, platelet-type, 16 | Enrichment | ITGA2B, ITGB3 | 3.20 |
| 48 | Periventricular nodular heterotopia 1 | Enrichment | FLNA, VWF | 3.20 |
| 49 | Langerhans cell histiocytosis | Enrichment | BRAF, MAP2K1 | 3.20 |
| 50 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | Enrichment | PIK3CA, PIK3R1 | 3.20 |
| 51 | Immunodeficiency 14a with lymphoproliferation, autosomal dominant | Enrichment | PIK3CD, PIK3R1 | 3.20 |
| 52 | Immunodeficiency 14 | Enrichment | PIK3CD, PIK3R1 | 3.20 |
| 53 | High bone mass osteogenesis imperfecta | Enrichment | COL1A1, COL1A2 | 3.20 |
| 54 | Multiple epiphyseal dysplasia | Enrichment | COL2A1, COMP | 3.20 |
| 55 | Thrombocytopenia | Enrichment | ACTN1, ITGA2B, ITGB3, SRC, VWF | 3.19 |
| 56 | Multiple sclerosis | Enrichment | ITGB4, LAMA5, LAMB1 | 3.00 |
| 57 | Osteoporosis | Enrichment | COL1A1, COL1A2, SRC | 3.00 |
| 58 | Lung cancer susceptibility 3 | Enrichment | BRAF, EGFR, ERBB2 | 3.00 |
| 59 | Dilated cardiomyopathy | Enrichment | BRAF, FLNC, LAMA2, MYL2, RAF1, VCL | 2.96 |
| 60 | Ehlers-danlos syndrome, arthrochalasia type, 1 | Enrichment | COL1A1, COL1A2 | 2.90 |
| 61 | Brain small vessel disease 1 with or without ocular anomalies | Enrichment | COL4A1, COL4A2 | 2.90 |
| 62 | Cardiofaciocutaneous syndrome 1 | Enrichment | BRAF, MAP2K1 | 2.90 |
| 63 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | CRKL, MAPK1 | 2.90 |
| 64 | Cardiofaciocutaneous syndrome | Enrichment | BRAF, MAP2K1 | 2.90 |
| 65 | Craniopharyngioma | Enrichment | BRAF, CTNNB1 | 2.90 |
| 66 | Noonan syndrome with multiple lentigines | Enrichment | BRAF, RAF1 | 2.90 |
| 67 | Osteogenesis imperfecta with normal sclerae, dominant form | Enrichment | COL1A1, COL1A2 | 2.90 |
| 68 | Familial hypertrophic cardiomyopathy | Enrichment | CAV3, FLNC, MYL2, RAF1 | 2.89 |
| 69 | Dandy-walker syndrome | Enrichment | BRAF, PDGFRB, PPP1CB | 2.75 |
| 70 | Martsolf syndrome 1 | Enrichment | ARHGAP35, ARHGAP5 | 2.69 |
| 71 | Insulin-like growth factor i | Enrichment | IGF1, IGF1R | 2.69 |
| 72 | Epidermolysis bullosa | Enrichment | ITGA6, LAMB3 | 2.69 |
| 73 | Primary hypereosinophilic syndrome | Enrichment | PDGFRA, PDGFRB | 2.69 |
| 74 | Familial porencephaly | Enrichment | COL4A1, COL4A2 | 2.69 |
| 75 | Osteogenesis imperfecta, type i | Enrichment | COL1A1, COL1A2 | 2.51 |
| 76 | Hemihyperplasia, isolated | Enrichment | PIK3CA, RHOA | 2.51 |
| 77 | Epidermolysis bullosa, junctional 5b, with pyloric atresia | Enrichment | ITGA6, ITGB4 | 2.51 |
| 78 | Anterior segment dysgenesis 5 | Enrichment | ARHGAP35, COL4A1 | 2.51 |
| 79 | Hemorrhage, intracerebral | Enrichment | COL4A1, COL4A2 | 2.51 |
| 80 | Breast adenocarcinoma | Enrichment | AKT1, PIK3CA | 2.51 |
| 81 | Lung squamous cell carcinoma | Enrichment | EGFR, PIK3CA | 2.51 |
| 82 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | COL1A1, COL5A2, FLNA, MYLK | 2.42 |
| 83 | Hepatocellular carcinoma | Enrichment | CTNNB1, MET, PIK3CA | 2.42 |
| 84 | Skin disease | Enrichment | ITGB4, LAMB3, LAMC2 | 2.42 |
| 85 | Nevus, epidermal | Enrichment | HRAS, PIK3CA | 2.37 |
| 86 | Osteogenesis imperfecta, type ii | Enrichment | COL1A1, COL1A2 | 2.37 |
| 87 | Squamous cell carcinoma, head and neck | Enrichment | EGFR, PTEN | 2.37 |
| 88 | Glanzmann thrombasthenia 1 | Enrichment | ITGA2B, ITGB3 | 2.37 |
| 89 | Capillary malformation-arteriovenous malformation 1 | Enrichment | MAP2K1, PIK3CA | 2.37 |
| 90 | Pilomyxoid astrocytoma | Enrichment | BRAF, RAF1 | 2.37 |
| 91 | Familial isolated restrictive cardiomyopathy | Enrichment | FLNC, MYL2 | 2.37 |
| 92 | Breast cancer | Enrichment | AKT1, JUN, PIK3CA, PTEN, SHC1 | 2.32 |
| 93 | Basal ganglia calcification, idiopathic, 1 | Enrichment | PDGFB, PDGFRB | 2.25 |
| 94 | Peters-plus syndrome | Enrichment | ARHGAP35, COL4A1 | 2.05 |
| 95 | Amelogenesis imperfecta, type ie | Enrichment | ITGB6, LAMB3 | 2.05 |
| 96 | Melanoma | Enrichment | BRAF, PTEN | 2.05 |
| 97 | Autosomal non-syndromic agammaglobulinemia | Enrichment | PIK3CD, PIK3R1 | 2.05 |
| 98 | Primary bone dysplasia | Enrichment | COL1A1, COL1A2 | 2.05 |
| 99 | Meningioma, familial | Enrichment | PDGFB, PTEN | 1.97 |
| 100 | Osteochondrodysplasia | Enrichment | COL1A1, COL1A2 | 1.97 |
| 101 | Genetic steroid-resistant nephrotic syndrome | Enrichment | ACTN4, EMP2, LAMA5 | 1.88 |
| 102 | Stickler syndrome, type i | Enrichment | COL2A1 | 1.84 |
| 103 | Arthritis, sacroiliac | Enrichment | RELN | 1.84 |
| 104 | Macrodactyly | Enrichment | PIK3CA | 1.84 |
| 105 | Boomerang dysplasia | Enrichment | FLNB | 1.84 |
| 106 | Proteus syndrome | Enrichment | AKT1 | 1.84 |
| 107 | Paget disease, extramammary | Enrichment | ERBB2 | 1.84 |
| 108 | Epiphyseal dysplasia, multiple, with myopia and conductive deafness | Enrichment | COL2A1 | 1.84 |
| 109 | Pseudoachondroplasia | Enrichment | COMP | 1.84 |
| 110 | Hypoinsulinemic hypoglycemia with hemihypertrophy | Enrichment | AKT2 | 1.84 |
| 111 | Ehlers-danlos syndrome, cardiac valvular type | Enrichment | COL1A2 | 1.84 |
| 112 | Spondylometaphyseal dysplasia, algerian type | Enrichment | COL2A1 | 1.84 |
| 113 | Von willebrand disease, type 1 | Enrichment | VWF | 1.84 |
| 114 | Baraitser-winter syndrome 1 | Enrichment | ACTB | 1.84 |
| 115 | Vacterl association with hydrocephalus | Enrichment | PTEN | 1.84 |
| 116 | Intellectual developmental disorder, x-linked 30 | Enrichment | PAK3 | 1.84 |
| 117 | Premature aging syndrome, penttinen type | Enrichment | PDGFRB | 1.84 |
| 118 | Focal segmental glomerulosclerosis 1 | Enrichment | ACTN4 | 1.84 |
| 119 | Lymphoproliferative syndrome, x-linked, 2 | Enrichment | XIAP | 1.84 |
| 120 | Osteoarthritis with mild chondrodysplasia | Enrichment | COL2A1 | 1.84 |
| 121 | Otopalatodigital syndrome, type i | Enrichment | FLNA | 1.84 |
| 122 | Intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked | Enrichment | FLNA | 1.84 |
| 123 | Avascular necrosis of femoral head, primary, 1 | Enrichment | COL2A1 | 1.84 |
| 124 | Noonan syndrome 5 | Enrichment | RAF1 | 1.84 |
| 125 | Hypomagnesemia 4, renal | Enrichment | EGF | 1.84 |
| 126 | Czech dysplasia | Enrichment | COL2A1 | 1.84 |
| 127 | Noonan syndrome 4 | Enrichment | SOS1 | 1.84 |
| 128 | Lipodystrophy, congenital generalized, type 3 | Enrichment | CAV1 | 1.84 |
| 129 | Hypereosinophilic syndrome, idiopathic | Enrichment | PDGFRA | 1.84 |
| 130 | Immunodeficiency 73a with defective neutrophil chemotaxis and leukocytosis | Enrichment | RAC2 | 1.84 |
| 131 | Deafness, autosomal recessive 39 | Enrichment | HGF | 1.84 |
| 132 | Melorheostosis, isolated | Enrichment | MAP2K1 | 1.84 |
| 133 | Megalencephaly, autosomal dominant | Enrichment | PIK3CA | 1.84 |
| 134 | Kniest dysplasia | Enrichment | COL2A1 | 1.84 |
| 135 | Noonan syndrome 7 | Enrichment | BRAF | 1.84 |
| 136 | Leopard syndrome 3 | Enrichment | BRAF | 1.84 |
| 137 | Cardiomyopathy, dilated, 1jj | Enrichment | LAMA4 | 1.84 |
| 138 | Basal ganglia calcification, idiopathic, 5 | Enrichment | PDGFB | 1.84 |
| 139 | Platyspondylic lethal skeletal dysplasia, torrance type | Enrichment | COL2A1 | 1.84 |
| 140 | Atelosteogenesis, type iii | Enrichment | FLNB | 1.84 |
| 141 | Deafness, autosomal dominant 1, with or without thrombocytopenia | Enrichment | DIAPH1 | 1.84 |
| 142 | Cardiomyopathy, dilated, 1nn | Enrichment | RAF1 | 1.84 |
| 143 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 | Enrichment | CCND2 | 1.84 |
| 144 | Atelosteogenesis, type i | Enrichment | FLNB | 1.84 |
| 145 | Cowden syndrome 5 | Enrichment | PIK3CA | 1.84 |
| 146 | Von willebrand disease, type 2 | Enrichment | VWF | 1.84 |
| 147 | Cardiofaciocutaneous syndrome 3 | Enrichment | MAP2K1 | 1.84 |
| 148 | Myofibromatosis, infantile, 1 | Enrichment | PDGFRB | 1.84 |
| 149 | Nephrotic syndrome, type 10 | Enrichment | EMP2 | 1.84 |
| 150 | Spondyloepiphyseal dysplasia, stanescu type | Enrichment | COL2A1 | 1.84 |
| 151 | Lissencephaly 5 | Enrichment | LAMB1 | 1.84 |
| 152 | Deafness, autosomal dominant 56 | Enrichment | TNC | 1.84 |
| 153 | Gist-plus syndrome | Enrichment | PDGFRA | 1.84 |
| 154 | Pulmonary hypertension, primary, 3 | Enrichment | CAV1 | 1.84 |
| 155 | Achondrogenesis, type ii | Enrichment | COL2A1 | 1.84 |
| 156 | Carpal tunnel syndrome 2 | Enrichment | COMP | 1.84 |
| 157 | Cerebral cavernous malformations 4 | Enrichment | PIK3CA | 1.84 |
| 158 | Visceral neuropathy, familial, 2, autosomal recessive | Enrichment | ERBB2 | 1.84 |
| 159 | Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus | Enrichment | TNR | 1.84 |
| 160 | Noonan syndrome 13 | Enrichment | MAPK1 | 1.84 |
| 161 | Nephrotic syndrome, type 26 | Enrichment | LAMA5 | 1.84 |
| 162 | Deafness, x-linked 6 | Enrichment | COL4A6 | 1.84 |
| 163 | Knobloch syndrome 2 | Enrichment | PAK2 | 1.84 |
| 164 | Terminal osseous dysplasia | Enrichment | FLNA | 1.84 |
| 165 | Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies | Enrichment | RAC3 | 1.84 |
| 166 | Ullrich congenital muscular dystrophy 1b | Enrichment | COL6A2 | 1.84 |
| 167 | Short syndrome | Enrichment | PIK3R1 | 1.84 |
| 168 | Intellectual developmental disorder with macrocephaly, seizures, and speech delay | Enrichment | PAK1 | 1.84 |
| 169 | Von willebrand disease, type 3 | Enrichment | VWF | 1.84 |
| 170 | Fetomaternal alloimmune thrombocytopenia 2 | Enrichment | ITGA2B | 1.84 |
| 171 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 2 | Enrichment | COL1A2 | 1.84 |
| 172 | Hereditary lymphedema id | Enrichment | VEGFC | 1.84 |
| 173 | Congenital smooth muscle hamartoma, with or without hemihypertrophy | Enrichment | ACTB | 1.84 |
| 174 | Fg syndrome 2 | Enrichment | FLNA | 1.84 |
| 175 | Osteofibrous dysplasia | Enrichment | MET | 1.84 |
| 176 | Spondyloperipheral dysplasia | Enrichment | COL2A1 | 1.84 |
| 177 | Myosclerosis, autosomal recessive | Enrichment | COL6A2 | 1.84 |
| 178 | Porencephaly | Enrichment | COL4A1 | 1.84 |
| 179 | Myeloid and lymphoid neoplasms associated with pdgfra rearrangement | Enrichment | PDGFRA | 1.84 |
| 180 | Immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia | Enrichment | RAC2 | 1.84 |
| 181 | Lymphatic malformation 4 | Enrichment | VEGFC | 1.84 |
| 182 | Papillary tumor of the pineal region | Enrichment | PTEN | 1.84 |
| 183 | Lipodystrophy, familial partial, type 7 | Enrichment | CAV1 | 1.84 |
| 184 | Deafness, autosomal recessive 97 | Enrichment | MET | 1.84 |
| 185 | Microvascular complications of diabetes 1 | Enrichment | VEGFA | 1.84 |
| 186 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 | Enrichment | AKT3 | 1.84 |
| 187 | Cardiomyopathy, dilated, 1w | Enrichment | VCL | 1.84 |
| 188 | Lymphangioma | Enrichment | BRAF | 1.84 |
| 189 | Hemifacial myohyperplasia | Enrichment | PIK3CA | 1.84 |
| 190 | Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth | Enrichment | PIK3CA | 1.84 |
| 191 | Phace association | Enrichment | BRAF | 1.84 |
| 192 | Spinocerebellar ataxia 14 | Enrichment | PRKCG | 1.84 |
| 193 | Otopalatodigital syndrome spectrum disorder | Enrichment | FLNA | 1.84 |
| 194 | Becker nevus syndrome | Enrichment | ACTB | 1.84 |
| 195 | Melorheostosis | Enrichment | MAP2K1 | 1.84 |
| 196 | Dystonia-deafness syndrome 1 | Enrichment | ACTB | 1.84 |
| 197 | Autism 9 | Enrichment | MET | 1.84 |
| 198 | Stickler syndrome, type i, nonsyndromic ocular | Enrichment | COL2A1 | 1.84 |
| 199 | Leopard syndrome 2 | Enrichment | RAF1 | 1.84 |
| 200 | Cortical malformations, occipital | Enrichment | LAMC3 | 1.84 |
| 201 | Cardiomyopathy, familial hypertrophic, 15 | Enrichment | VCL | 1.84 |
| 202 | Basal ganglia calcification, idiopathic, 4 | Enrichment | PDGFRB | 1.84 |
| 203 | Immunodeficiency 36 with lymphoproliferation | Enrichment | PIK3R1 | 1.84 |
| 204 | Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies | Enrichment | RAP1B | 1.84 |
| 205 | Cowden syndrome 6 | Enrichment | AKT1 | 1.84 |
| 206 | Bleeding disorder, platelet-type, 15 | Enrichment | ACTN1 | 1.84 |
| 207 | Synovitis | Enrichment | RELN | 1.84 |
| 208 | Immunodeficiency 14b, autosomal recessive | Enrichment | PIK3CD | 1.84 |
| 209 | Myeloid and lymphoid neoplasms associated with pdgfrb rearrangement | Enrichment | PDGFRB | 1.84 |
| 210 | Agammaglobulinemia 7, autosomal recessive | Enrichment | PIK3R1 | 1.84 |
| 211 | Glioma susceptibility 2 | Enrichment | PTEN | 1.84 |
| 212 | Kosaki overgrowth syndrome | Enrichment | PDGFRB | 1.84 |
| 213 | Thrombocytopenia 6 | Enrichment | SRC | 1.84 |
| 214 | X-linked ehlers-danlos syndrome | Enrichment | FLNA | 1.84 |
| 215 | Seizures, cortical blindness, and microcephaly syndrome | Enrichment | DIAPH1 | 1.84 |
| 216 | Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies | Enrichment | RHOA | 1.84 |
| 217 | Takenouchi-kosaki syndrome | Enrichment | CDC42 | 1.84 |
| 218 | Noonan syndrome-like disorder with loose anagen hair 2 | Enrichment | PPP1CB | 1.84 |
| 219 | Diaph1-related sensorineural hearing loss-thrombocytopenia syndrome | Enrichment | DIAPH1 | 1.84 |
| 220 | Von willebrand's disease | Enrichment | VWF | 1.84 |
| 221 | Thrombocytopenia 8, with dysmorphic features and developmental delay | Enrichment | ACTB | 1.84 |
| 222 | Qualitative or quantitative defects of collagen 6 | Enrichment | COL6A2 | 1.84 |
| 223 | Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression | Enrichment | TNK2 | 1.84 |
| 224 | Ocular pterygium-digital keloid dysplasia syndrome | Enrichment | PDGFRB | 1.84 |
| 225 | Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies | Enrichment | RHOA | 1.84 |
| 226 | Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia | Enrichment | RAC2 | 1.84 |
| 227 | Trigonitis | Enrichment | RAF1 | 1.84 |
| 228 | Bent bone dysplasia syndrome 2 | Enrichment | LAMA5 | 1.84 |
| 229 | Vitreoretinopathy with phalangeal epiphyseal dysplasia | Enrichment | COL2A1 | 1.84 |
| 230 | Segmental progressive overgrowth syndrome with fibroadipose hyperplasia | Enrichment | PIK3CA | 1.84 |
| 231 | Tufted angioma of skin | Enrichment | KDR | 1.84 |
| 232 | Asphyxia neonatorum | Enrichment | COL1A1 | 1.84 |
| 233 | Bethlem myopathy 1b | Enrichment | COL6A2 | 1.84 |
| 234 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 1.84 |
| 235 | Arthrogryposis, distal, type 11 | Enrichment | MET | 1.84 |
| 236 | Amelogenesis imperfecta, type ih | Enrichment | ITGB6 | 1.84 |
| 237 | Baraitser-winter syndrome | Enrichment | ACTB | 1.84 |
| 238 | Autoinflammation with pulmonary and cutaneous vasculitis | Enrichment | HCK | 1.84 |
| 239 | Col4a1-related disorders | Enrichment | COL4A1 | 1.84 |
| 240 | Occipital pachygyria and polymicrogyria | Enrichment | LAMC3 | 1.84 |
| 241 | Hypospadias | Enrichment | PIK3CA | 1.84 |
| 242 | Capillary hemangioma | Enrichment | AKT3 | 1.84 |
| 243 | Flnb-related disorders | Enrichment | FLNB | 1.84 |
| 244 | Autosomal dominant rhegmatogenous retinal detachment | Enrichment | COL2A1 | 1.84 |
| 245 | Rare venous malformation | Enrichment | PIK3CA | 1.84 |
| 246 | Fetomaternal alloimmune thrombocytopenia 3 | Enrichment | ITGA2 | 1.84 |
| 247 | Col4a1 or col4a2-related cerebral small vessel disease | Enrichment | COL4A1 | 1.84 |
| 248 | Multiple epiphyseal dysplasia with myopia and deafness | Enrichment | COL2A1 | 1.84 |
| 249 | Immune dysregulation, neurodevelopmental defects, and colitis | Enrichment | ITGAV | 1.84 |
| 250 | Diaphragmatic eventration | Enrichment | PIK3CA | 1.84 |
| 251 | Hypochondrogenesis | Enrichment | COL2A1 | 1.84 |
| 252 | Infantile lad-like disease due to rac2 deficiency | Enrichment | RAC2 | 1.84 |
| 253 | Congenital smooth muscle hamartoma | Enrichment | ACTB | 1.84 |
| 254 | Capillary leak syndrome | Enrichment | TLN1 | 1.84 |
| 255 | Reticular dysgenesis-like severe combined immunodeficiency | Enrichment | RAC2 | 1.84 |
| 256 | Nocarh syndrome | Enrichment | CDC42 | 1.84 |
| 257 | Pik3ca-related overgrowth spectrum | Enrichment | PIK3CA | 1.84 |
| 258 | Congenital primary lymphedema of gordon | Enrichment | VEGFC | 1.84 |
| 259 | Syringocystadenoma papilliferum | Enrichment | BRAF | 1.84 |
| 260 | Developmental malformations-deafness-dystonia syndrome | Enrichment | ACTB | 1.84 |
| 261 | Dysspondyloenchondromatosis | Enrichment | COL2A1 | 1.84 |
| 262 | Rare combined vascular malformation | Enrichment | PIK3CA | 1.84 |
| 263 | Ganglioglioma | Enrichment | BRAF | 1.84 |
| 264 | Cavernous lymphangioma | Enrichment | PIK3CA | 1.84 |
| 265 | Pik3ca-related overgrowth syndrome | Enrichment | PIK3CA | 1.84 |
| 266 | Nongerminomatous germ cell tumor | Enrichment | BRAF | 1.84 |
| 267 | Phace syndrome | Enrichment | BRAF | 1.84 |
| 268 | X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome | Enrichment | FLNA | 1.84 |
| 269 | Phakomatosis pigmentokeratotica | Enrichment | HRAS | 1.84 |
| 270 | Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome | Enrichment | PTEN | 1.84 |
| 271 | Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom | Enrichment | RAC1 | 1.84 |
| 272 | Classic hairy cell leukemia | Enrichment | BRAF | 1.84 |
| 273 | Type 2 collagen-related bone disorder | Enrichment | COL2A1 | 1.84 |
| 274 | Hemihyperplasia-multiple lipomatosis syndrome | Enrichment | PIK3CA | 1.84 |
| 275 | Lama5-related multisystemic syndrome | Enrichment | LAMA5 | 1.84 |
| 276 | Eccrine angiomatous hamartoma | Enrichment | PIK3CA | 1.84 |
| 277 | Rac2-related combined immunodeficiency-bronchiectasis-cancer-predisposing syndrome | Enrichment | RAC2 | 1.84 |
| 278 | Egf-related primary hypomagnesemia with intellectual disability | Enrichment | EGF | 1.84 |
| 279 | Macrodactyly of toe | Enrichment | PIK3CA | 1.84 |
| 280 | Serous carcinoma of the corpus uteri | Enrichment | ERBB2 | 1.84 |
| 281 | Microcystic stromal tumor | Enrichment | CTNNB1 | 1.84 |
| 282 | Temporomandibular joint anomaly | Enrichment | DOCK1 | 1.84 |
| 283 | Laminin subunit alpha 2-related muscular dystrophy | Enrichment | LAMA2 | 1.84 |
| 284 | Akt2-related familial partial lipodystrophy | Enrichment | AKT2 | 1.84 |
| 285 | Osteogenesis imperfecta, type iv | Enrichment | COL1A1, COL1A2 | 1.83 |
| 286 | Nk-cell enteropathy | Enrichment | IGF1R, PIK3CB | 1.83 |
| 287 | Cerebral palsy | Enrichment | COL4A1, COL4A2, PDGFRB | 1.72 |
| 288 | Congenital myopathy 4a, autosomal dominant | Enrichment | ITGA7, MYL2 | 1.71 |
| 289 | Osteogenesis imperfecta, type iii | Enrichment | COL1A1, COL1A2 | 1.71 |
| 290 | Myopia | Enrichment | COL2A1, COL4A4 | 1.71 |
| 291 | Kidney disease | Enrichment | COL4A4, LAMB2 | 1.71 |
| 292 | Creatine phosphokinase, elevated serum | Enrichment | CAV3, LAMA2 | 1.65 |
| 293 | Isolated elevated serum creatine phosphokinase levels | Enrichment | CAV3, LAMA2 | 1.65 |
| 294 | Rhabdomyosarcoma | Enrichment | HRAS, PTEN | 1.65 |
| 295 | Gastric cancer | Enrichment | ERBB2, PIK3CA, PTEN | 1.61 |
| 296 | Hereditary breast carcinoma | Enrichment | AKT1, PIK3CA, PTEN | 1.58 |
| 297 | Heart, malformation of | Enrichment | COL2A1, MAPK1 | 1.56 |
| 298 | Patent foramen ovale | Enrichment | FLNA, FLNC | 1.56 |
| 299 | Amelogenesis imperfecta, type ia | Enrichment | LAMB3 | 1.54 |
| 300 | Ehlers-danlos syndrome, hypermobility type | Enrichment | TNXB | 1.54 |
| 301 | Myeloproliferative disorder, chronic, with eosinophilia | Enrichment | PDGFRB | 1.54 |
| 302 | Fibromatosis, gingival, 1 | Enrichment | SOS1 | 1.54 |
| 303 | Costello syndrome | Enrichment | HRAS | 1.54 |
| 304 | Epidermolysis bullosa, junctional 2c, laryngoonychocutaneous | Enrichment | LAMA3 | 1.54 |
| 305 | Bruck syndrome 1 | Enrichment | COL1A2 | 1.54 |
| 306 | Visceral neuropathy, familial, 1, autosomal recessive | Enrichment | FLNA | 1.54 |
| 307 | Otospondylomegaepiphyseal dysplasia, autosomal recessive | Enrichment | COL2A1 | 1.54 |
| 308 | Myasthenic syndrome, congenital, 5 | Enrichment | LAMB2 | 1.54 |
| 309 | Otopalatodigital syndrome, type ii | Enrichment | FLNA | 1.54 |
| 310 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 1.54 |
| 311 | Melnick-needles syndrome | Enrichment | FLNA | 1.54 |
| 312 | Frontometaphyseal dysplasia 1 | Enrichment | FLNA | 1.54 |
| 313 | Lethal congenital contracture syndrome 3 | Enrichment | PIP5K1C | 1.54 |
| 314 | Legg-calve-perthes disease | Enrichment | COL2A1 | 1.54 |
| 315 | Deafness, autosomal dominant 20 | Enrichment | ACTG1 | 1.54 |
| 316 | Keratosis, seborrheic | Enrichment | PIK3CA | 1.54 |
| 317 | Lissencephaly 1 | Enrichment | LAMB1 | 1.54 |
| 318 | Roifman-chitayat syndrome | Enrichment | PIK3CD | 1.54 |
| 319 | Maturity-onset diabetes of the young, type 11 | Enrichment | BLK | 1.54 |
| 320 | Baraitser-winter syndrome 2 | Enrichment | ACTG1 | 1.54 |
| 321 | Specific language impairment 5 | Enrichment | COL4A4 | 1.54 |
| 322 | Angioma, tufted | Enrichment | KDR | 1.54 |
| 323 | Otospondylomegaepiphyseal dysplasia, autosomal dominant | Enrichment | COL2A1 | 1.54 |
| 324 | Noonan syndrome 8 | Enrichment | PIK3CA | 1.54 |
| 325 | Pierson syndrome | Enrichment | LAMB2 | 1.54 |
| 326 | Genitourinary and/or brain malformation syndrome | Enrichment | PPP1R12A | 1.54 |
| 327 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | Enrichment | COL4A2 | 1.54 |
| 328 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 1 | Enrichment | COL1A1 | 1.54 |
| 329 | Epidermolysis bullosa, junctional 3b, severe | Enrichment | LAMC2 | 1.54 |
| 330 | Epidermolysis bullosa, junctional 3a, intermediate | Enrichment | LAMC2 | 1.54 |
| 331 | Intellectual developmental disorder, autosomal dominant 48 | Enrichment | RAC1 | 1.54 |
| 332 | Epidermolysis bullosa, junctional 2a, intermediate | Enrichment | LAMA3 | 1.54 |
| 333 | Epidermolysis bullosa, junctional 5a, intermediate | Enrichment | ITGB4 | 1.54 |
| 334 | Cardiac valvular dysplasia, x-linked | Enrichment | FLNA | 1.54 |
| 335 | Infantile myofibromatosis | Enrichment | PDGFRB | 1.54 |
| 336 | Intravascular large b-cell lymphoma | Enrichment | BCL2 | 1.54 |
| 337 | Nephrotic syndrome, type 5, with or without ocular abnormalities | Enrichment | LAMB2 | 1.54 |
| 338 | Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome | Enrichment | ITGA3 | 1.54 |
| 339 | Noonan syndrome-like disorder with loose anagen hair | Enrichment | PPP1CB | 1.54 |
| 340 | Senior-loken syndrome 7 | Enrichment | AKT3 | 1.54 |
| 341 | Rosette-forming glioneuronal tumor | Enrichment | PIK3CA | 1.54 |
| 342 | Cardiovascular system disease | Enrichment | FLNC | 1.54 |
| 343 | Cardiomyopathy, familial hypertrophic, 10 | Enrichment | MYL2 | 1.54 |
| 344 | Papillary renal cell carcinoma | Enrichment | MET | 1.54 |
| 345 | Glomerulonephritis | Enrichment | COL4A4 | 1.54 |
| 346 | Stickler syndrome, type ii | Enrichment | COL1A1 | 1.54 |
| 347 | Familial avascular necrosis of the femoral head | Enrichment | COL2A1 | 1.54 |
| 348 | Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy | Enrichment | MYL2 | 1.54 |
| 349 | Bardet-biedl syndrome 16 | Enrichment | AKT3 | 1.54 |
| 350 | Epidermolysis bullosa, junctional 2b, severe | Enrichment | LAMA3 | 1.54 |
| 351 | Arthrogryposis, distal, type 1c | Enrichment | MYL11 | 1.54 |
| 352 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 | Enrichment | MYL9 | 1.54 |
| 353 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 1.54 |
| 354 | Localized junctional epidermolysis bullosa, non-herlitz type | Enrichment | ITGB4 | 1.54 |
| 355 | Chronic eosinophilic leukemia | Enrichment | PDGFRA | 1.54 |
| 356 | Vacterl with hydrocephalus | Enrichment | PTEN | 1.54 |
| 357 | Growth delay due to insulin-like growth factor type 1 deficiency | Enrichment | IGF1 | 1.54 |
| 358 | Arthritis | Enrichment | RELN | 1.54 |
| 359 | Dentinogenesis imperfecta | Enrichment | COL1A2 | 1.54 |
| 360 | Qualitative or quantitative defects of caveolin-3 | Enrichment | CAV3 | 1.54 |
| 361 | Teratoma | Enrichment | CTNNB1 | 1.54 |
| 362 | B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality | Enrichment | PDGFRA | 1.54 |
| 363 | Juvenile polyposis of infancy | Enrichment | PTEN | 1.54 |
| 364 | X-linked diffuse leiomyomatosis-alport syndrome | Enrichment | COL4A6 | 1.54 |
| 365 | Wooly hair nevus | Enrichment | HRAS | 1.54 |
| 366 | Arteriovenous malformations of the brain | Enrichment | BRAF, EGFR | 1.51 |
| 367 | Diffuse large b-cell lymphoma | Enrichment | BRAF, PTEN | 1.51 |
| 368 | Endometrial cancer | Enrichment | PIK3CA, PTEN | 1.43 |
| 369 | Lissencephaly | Enrichment | ACTG1, RELN | 1.43 |
| 370 | Familial isolated dilated cardiomyopathy | Enrichment | LAMA4, RAF1, VCL | 1.38 |
| 371 | Desmoid disease, hereditary | Enrichment | CTNNB1 | 1.36 |
| 372 | Hyper-ige syndrome 1, autosomal dominant, with recurrent infections | Enrichment | ITGB3 | 1.36 |
| 373 | Prune belly syndrome | Enrichment | FLNA | 1.36 |
| 374 | Mccune-albright syndrome | Enrichment | COL2A1 | 1.36 |
| 375 | Retinal arteries, tortuosity of | Enrichment | COL4A1 | 1.36 |
| 376 | Larsen syndrome | Enrichment | FLNB | 1.36 |
| 377 | Hematuria, benign familial, 1 | Enrichment | COL4A4 | 1.36 |
| 378 | Ataxia-telangiectasia | Enrichment | BRAF | 1.36 |
| 379 | Spondyloepiphyseal dysplasia congenita | Enrichment | COL2A1 | 1.36 |
| 380 | Arterial tortuosity syndrome | Enrichment | FLNA | 1.36 |
| 381 | Pompe disease, infantile-onset | Enrichment | PIK3CA | 1.36 |
| 382 | Telecanthus | Enrichment | COL5A2 | 1.36 |
| 383 | Myopathy, myofibrillar, 5 | Enrichment | FLNC | 1.36 |
| 384 | Glomerulopathy with fibronectin deposits 2 | Enrichment | FN1 | 1.36 |
| 385 | Nuchal bleb, familial | Enrichment | SOS1 | 1.36 |
| 386 | Ehlers-danlos syndrome, classic-like, 1 | Enrichment | TNXB | 1.36 |
| 387 | Rippling muscle disease 2 | Enrichment | CAV3 | 1.36 |
| 388 | Spondylocarpotarsal synostosis syndrome | Enrichment | FLNB | 1.36 |
| 389 | Ehlers-danlos syndrome, classic type, 2 | Enrichment | COL5A2 | 1.36 |
| 390 | Muscular dystrophy, congenital merosin-deficient, 1a | Enrichment | LAMA2 | 1.36 |
| 391 | Long qt syndrome 9 | Enrichment | CAV3 | 1.36 |
| 392 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 1.36 |
| 393 | Aortic aneurysm, familial thoracic 7 | Enrichment | MYLK | 1.36 |
| 394 | Congenital short bowel syndrome | Enrichment | FLNA | 1.36 |
| 395 | Caffey disease | Enrichment | COL1A1 | 1.36 |
| 396 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | Enrichment | ITGA7 | 1.36 |
| 397 | Brain small vessel disease 2 | Enrichment | COL4A2 | 1.36 |
| 398 | Myopathy, distal, tateyama type | Enrichment | CAV3 | 1.36 |
| 399 | Epilepsy, familial temporal lobe, 7 | Enrichment | RELN | 1.36 |
| 400 | Neonatal nephrocutaneous inflammatory syndrome | Enrichment | EGFR | 1.36 |
| 401 | Myopathy, distal, 4 | Enrichment | FLNC | 1.36 |
| 402 | Anus, imperforate | Enrichment | CTNNB1 | 1.36 |
| 403 | Microangiopathy and leukoencephalopathy, pontine, autosomal dominant | Enrichment | COL4A1 | 1.36 |
| 404 | Vesicoureteral reflux 8 | Enrichment | TNXB | 1.36 |
| 405 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 1.36 |
| 406 | Epidermolysis bullosa, junctional 6, with pyloric atresia | Enrichment | ITGA6 | 1.36 |
| 407 | Ehlers-danlos syndrome, classic-like, 3 | Enrichment | THBS2 | 1.36 |
| 408 | Tethered spinal cord syndrome | Enrichment | BRAF | 1.36 |
| 409 | Large congenital melanocytic nevus | Enrichment | HRAS | 1.36 |
| 410 | Desmoid tumor | Enrichment | CTNNB1 | 1.36 |
| 411 | High-grade b-cell lymphoma double-hit/triple-hit | Enrichment | BCL2 | 1.36 |
| 412 | Poretti-boltshauser syndrome | Enrichment | LAMA1 | 1.36 |
| 413 | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps | Enrichment | COL4A1 | 1.36 |
| 414 | Frontometaphyseal dysplasia | Enrichment | FLNA | 1.36 |
| 415 | Kyphosis | Enrichment | RELN | 1.36 |
| 416 | Familial vesicoureteral reflux | Enrichment | TNXB | 1.36 |
| 417 | Laryngeal squamous cell carcinoma | Enrichment | PTEN | 1.36 |
| 418 | Spermatocytoma | Enrichment | HRAS | 1.36 |
| 419 | Collagen vi-related dystrophies | Enrichment | COL6A2 | 1.36 |
| 420 | Growth delay due to insulin-like growth factor i resistance | Enrichment | IGF1R | 1.36 |
| 421 | Bleeding disorder, platelet-type, 24 | Enrichment | ITGB3 | 1.36 |
| 422 | Neonatal inflammatory skin and bowel disease | Enrichment | EGFR | 1.36 |
| 423 | Intermediate collagen vi-related muscular dystrophy | Enrichment | COL6A2 | 1.36 |
| 424 | Alopecia - intellectual disability syndrome | Enrichment | ITGB6 | 1.36 |
| 425 | Renal cell carcinoma | Enrichment | MET | 1.36 |
| 426 | Keratoacanthoma | Enrichment | PIK3CA | 1.36 |
| 427 | Digenic alport syndrome | Enrichment | COL4A4 | 1.36 |
| 428 | Epilepsy with auditory features | Enrichment | RELN | 1.36 |
| 429 | Lama2-related muscular dystrophy | Enrichment | LAMA2 | 1.36 |
| 430 | Brittle bone disorder | Enrichment | COL1A1, COL1A2 | 1.36 |
| 431 | Scoliosis | Enrichment | COL2A1, RELN | 1.32 |
| 432 | Myeloma, multiple | Enrichment | BRAF, CCND1, PIK3R2 | 1.32 |
| 433 | Tetralogy of fallot | Enrichment | FLNC, KDR | 1.26 |
| 434 | Amelogenesis imperfecta, type iiia | Enrichment | ITGB6 | 1.24 |
| 435 | Schimmelpenning-feuerstein-mims syndrome | Enrichment | HRAS | 1.24 |
| 436 | Alport syndrome 2, autosomal recessive | Enrichment | COL4A4 | 1.24 |
| 437 | Phenylketonuria | Enrichment | COL1A1 | 1.24 |
| 438 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 | Enrichment | MYLK | 1.24 |
| 439 | Schizencephaly | Enrichment | COL4A1 | 1.24 |
| 440 | Thyroid cancer, nonmedullary, 1 | Enrichment | BRAF | 1.24 |
| 441 | Epidermolysis bullosa simplex 5c, with pyloric atresia | Enrichment | ITGB4 | 1.24 |
| 442 | Pilomatrixoma | Enrichment | CTNNB1 | 1.24 |
| 443 | Retinitis pigmentosa 26 | Enrichment | ITGA4 | 1.24 |
| 444 | Lymphoproliferative syndrome 2 | Enrichment | XIAP | 1.24 |
| 445 | Barrett esophagus | Enrichment | ERBB2 | 1.24 |
| 446 | Aminoacylase 1 deficiency | Enrichment | ACTB | 1.24 |
| 447 | Cardiomyopathy, familial hypertrophic, 26 | Enrichment | FLNC | 1.24 |
| 448 | Alazami syndrome | Enrichment | CTNNB1 | 1.24 |
| 449 | Mantle cell lymphoma | Enrichment | CCND1 | 1.24 |
| 450 | Hereditary ataxia | Enrichment | PRKCG | 1.24 |
| 451 | Cerebrovascular disease | Enrichment | PIK3CA | 1.24 |
| 452 | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia | Enrichment | CDC42 | 1.24 |
| 453 | Newborn respiratory distress syndrome | Enrichment | BRAF | 1.24 |
| 454 | Epidermolytic nevus | Enrichment | HRAS | 1.24 |
| 455 | Familial cerebral cavernous malformations | Enrichment | PIK3CA | 1.24 |
| 456 | Knobloch syndrome | Enrichment | PAK2 | 1.24 |
| 457 | Autosomal recessive alport syndrome | Enrichment | COL4A4 | 1.24 |
| 458 | Pediatric systemic lupus erythematosus | Enrichment | SPP1 | 1.24 |
| 459 | Glioma | Enrichment | PTEN | 1.24 |
| 460 | Bethlem muscular dystrophy | Enrichment | COL6A2 | 1.24 |
| 461 | Rare x-linked non-syndromic sensorineural deafness type dfn | Enrichment | COL4A6 | 1.24 |
| 462 | Gingival fibromatosis | Enrichment | SOS1 | 1.24 |
| 463 | Pseudomyogenic hemangioendothelioma | Enrichment | ACTB | 1.24 |
| 464 | Prostate cancer | Enrichment | PIK3CA, PTEN | 1.18 |
| 465 | Differentiated thyroid carcinoma | Enrichment | BRAF, HRAS | 1.18 |
| 466 | Alport syndrome 3a, autosomal dominant | Enrichment | COL4A4 | 1.15 |
| 467 | Hemifacial hyperplasia | Enrichment | FLNC | 1.15 |
| 468 | Lymphoma, mucosa-associated lymphoid type | Enrichment | BIRC3 | 1.15 |
| 469 | Capillary malformations, congenital | Enrichment | PIK3CA | 1.15 |
| 470 | Visceral myopathy 1 | Enrichment | MYLK | 1.15 |
| 471 | Retinal detachment | Enrichment | COL2A1 | 1.15 |
| 472 | Epidermolysis bullosa simplex 1c, localized | Enrichment | ITGB4 | 1.15 |
| 473 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1 | 1.15 |
| 474 | Ullrich congenital muscular dystrophy 1a | Enrichment | COL6A2 | 1.15 |
| 475 | Von hippel-lindau syndrome | Enrichment | CCND1 | 1.15 |
| 476 | Macrocephaly/autism syndrome | Enrichment | PTEN | 1.15 |
| 477 | Knobloch syndrome 1 | Enrichment | PAK2 | 1.15 |
| 478 | Mosaic variegated aneuploidy syndrome 1 | Enrichment | PAK6 | 1.15 |
| 479 | Lissencephaly 2 | Enrichment | RELN | 1.15 |
| 480 | Glanzmann thrombasthenia 2 | Enrichment | ITGB3 | 1.15 |
| 481 | Muscular dystrophy, limb-girdle, autosomal recessive 23 | Enrichment | LAMA2 | 1.15 |
| 482 | Pre-eclampsia | Enrichment | FLT1 | 1.15 |
| 483 | Follicular lymphoma | Enrichment | BCL2 | 1.15 |
| 484 | Heart conduction disease | Enrichment | FLNC | 1.15 |
| 485 | Autosomal dominant alport syndrome | Enrichment | COL4A4 | 1.15 |
| 486 | Hemangioma | Enrichment | PTEN | 1.15 |
| 487 | Aplasia cutis congenita | Enrichment | ITGB4 | 1.15 |
| 488 | Acute megakaryocytic leukemia | Enrichment | PTEN | 1.15 |
| 489 | Alport syndrome | Enrichment | COL4A4 | 1.15 |
| 490 | Coloboma of choroid and retina | Enrichment | ACTG1 | 1.15 |
| 491 | Diffuse cutaneous systemic sclerosis | Enrichment | CAV1 | 1.15 |
| 492 | Connective tissue disease | Enrichment | COL2A1, FLNB | 1.10 |
| 493 | Developmental dysplasia of the hip 1 | Enrichment | COL2A1 | 1.07 |
| 494 | Klippel-trenaunay-weber syndrome | Enrichment | PIK3CA | 1.07 |
| 495 | Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency | Enrichment | TNXB | 1.07 |
| 496 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.07 |
| 497 | Moyamoya disease 1 | Enrichment | DIAPH1 | 1.07 |
| 498 | Wilms tumor 5 | Enrichment | BRAF | 1.07 |
| 499 | Hemangioma, capillary infantile | Enrichment | KDR | 1.07 |
| 500 | Pendred syndrome | Enrichment | DIAPH1 | 1.07 |
| 501 | Patent ductus arteriosus | Enrichment | FLNA | 1.07 |
| 502 | Adrenocortical carcinoma | Enrichment | CTNNB1 | 1.07 |
| 503 | Limited scleroderma | Enrichment | CAV1 | 1.07 |
| 504 | Inherited arrhythmogenic cardiomyopathy | Enrichment | FLNC | 1.07 |
| 505 | 21-hydroxylase-deficient congenital adrenal hyperplasia | Enrichment | TNXB | 1.07 |
| 506 | Cakut | Enrichment | ACTG1, COL4A1 | 1.06 |
| 507 | Bethlem myopathy 1a | Enrichment | COL6A2 | 1.01 |
| 508 | Myelofibrosis | Enrichment | SRC | 1.01 |
| 509 | Intervertebral disc disease | Enrichment | THBS2 | 1.01 |
| 510 | Gastrointestinal stromal tumor | Enrichment | PDGFRA | 1.01 |
| 511 | Renal cell carcinoma, papillary, 1 | Enrichment | MET | 1.01 |
| 512 | Multiple enchondromatosis, maffucci type | Enrichment | COL2A1 | 1.01 |
| 513 | Megacolon | Enrichment | AKT3 | 1.01 |
| 514 | Epidermolysis bullosa simplex | Enrichment | ITGB4 | 1.01 |
| 515 | Myofibrillar myopathy | Enrichment | FLNC | 1.01 |
| 516 | Overgrowth syndrome | Enrichment | PIK3R1 | 1.01 |
| 517 | Systemic lupus erythematosus | Enrichment | BLK, SPP1 | 0.96 |
| 518 | Arthrogryposis, distal, type 1a | Enrichment | MET | 0.95 |
| 519 | Glioma susceptibility 1 | Enrichment | ERBB2 | 0.95 |
| 520 | Myopathy, tubular aggregate, 1 | Enrichment | CAV3 | 0.95 |
| 521 | Fanconi anemia, complementation group c | Enrichment | FLNA | 0.95 |
| 522 | Renal hypodysplasia/aplasia 1 | Enrichment | ITGA8 | 0.95 |
| 523 | Lymphoma, non-hodgkin, familial | Enrichment | BRAF | 0.95 |
| 524 | Lennox-gastaut syndrome | Enrichment | MAPK10 | 0.95 |
| 525 | Exudative vitreoretinopathy | Enrichment | CTNNB1 | 0.95 |
| 526 | Congenital muscular dystrophy | Enrichment | LAMA2 | 0.95 |
| 527 | Mosaic variegated aneuploidy syndrome | Enrichment | PAK6 | 0.95 |
| 528 | Cardiomyopathy, familial hypertrophic, 4 | Enrichment | BRAF | 0.91 |
| 529 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | Enrichment | RAC1 | 0.91 |
| 530 | Primary hyperaldosteronism | Enrichment | BRAF | 0.91 |
| 531 | Ventricular septal defect | Enrichment | BRAF | 0.91 |
| 532 | Familial thoracic aortic aneurysm and dissection | Enrichment | MYLK | 0.91 |
| 533 | Renal agenesis, bilateral | Enrichment | ITGA8 | 0.91 |
| 534 | Inherited cancer-predisposing syndrome | Enrichment | EGFR, MET, PDGFRA, PTEN | 0.89 |
| 535 | Cat eye syndrome | Enrichment | ACTG1 | 0.86 |
| 536 | Marfan syndrome | Enrichment | COL2A1 | 0.86 |
| 537 | Leukemia, chronic lymphocytic | Enrichment | CCND1 | 0.86 |
| 538 | Stickler syndrome | Enrichment | COL2A1 | 0.86 |
| 539 | Polymicrogyria | Enrichment | AKT3 | 0.86 |
| 540 | Nemaline myopathy | Enrichment | FLNC | 0.86 |
| 541 | Uterine corpus cancer | Enrichment | PTEN | 0.83 |
| 542 | Heritable pulmonary arterial hypertension | Enrichment | CAV1 | 0.83 |
| 543 | Specific learning disability | Enrichment | MAPK1 | 0.83 |
| 544 | Presynaptic congenital myasthenic syndromes | Enrichment | LAMA5 | 0.83 |
| 545 | Cardiac conduction defect | Enrichment | FLNC | 0.79 |
| 546 | Restrictive cardiomyopathy | Enrichment | FLNC | 0.79 |
| 547 | Aortic valve disease 1 | Enrichment | SOS1 | 0.76 |
| 548 | Neural tube defects | Enrichment | ITGB1 | 0.76 |
| 549 | Amelogenesis imperfecta | Enrichment | LAMB3 | 0.76 |
| 550 | Chronic kidney disease | Enrichment | COL4A4 | 0.76 |
| 551 | Hypertelorism | Enrichment | COL1A1, PIK3CA | 0.76 |
| 552 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | ACTG1, TNC | 0.76 |
| 553 | Medulloblastoma | Enrichment | CTNNB1 | 0.73 |
| 554 | Lipoid congenital adrenal hyperplasia | Enrichment | TNXB | 0.73 |
| 555 | Aortic aneurysm, familial thoracic 1 | Enrichment | MYLK | 0.73 |
| 556 | Periventricular nodular heterotopia | Enrichment | FLNA | 0.73 |
| 557 | Walker-warburg syndrome | Enrichment | COL4A1 | 0.73 |
| 558 | Heart disease | Enrichment | MYL2 | 0.73 |
| 559 | Cleft lip/palate | Enrichment | PDGFRA | 0.73 |
| 560 | 46,xy partial gonadal dysgenesis | Enrichment | SOS1 | 0.73 |
| 561 | Isolated macular dystrophy | Enrichment | ITGA4 | 0.73 |
| 562 | Hereditary breast ovarian cancer syndrome | Enrichment | BCAR1, PTEN | 0.72 |
| 563 | Renal cell carcinoma, nonpapillary | Enrichment | MET | 0.70 |
| 564 | Wilms tumor 1 | Enrichment | BRAF | 0.70 |
| 565 | Corpus callosum, agenesis of | Enrichment | COL4A1 | 0.70 |
| 566 | Hydrocephalus | Enrichment | PDGFRB | 0.70 |
| 567 | Anterior segment dysgenesis | Enrichment | COL4A1 | 0.70 |
| 568 | Lynch syndrome | Enrichment | PIK3CA | 0.70 |
| 569 | Isolated corpus callosum agenesis | Enrichment | COL4A1 | 0.70 |
| 570 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | COL4A1 | 0.70 |
| 571 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | FLNC | 0.68 |
| 572 | Hypertension | Enrichment | COL4A4 | 0.68 |
| 573 | Gliosarcoma | Enrichment | EGFR | 0.68 |
| 574 | Primary ovarian insufficiency | Enrichment | KDR, THBS1 | 0.67 |
| 575 | Melanoma, cutaneous malignant 1 | Enrichment | BRAF | 0.66 |
| 576 | Cleft palate, isolated | Enrichment | FLNA | 0.66 |
| 577 | Sudden infant death syndrome | Enrichment | CAV3 | 0.66 |
| 578 | Cardiomyopathy, dilated, 1e | Enrichment | MYL2 | 0.66 |
| 579 | Polycystic liver disease | Enrichment | CTNNB1 | 0.66 |
| 580 | Giant cell glioblastoma | Enrichment | EGFR | 0.66 |
| 581 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 0.66 |
| 582 | Polycystic kidney disease | Enrichment | COL4A4 | 0.63 |
| 583 | Parkinson's disease | Enrichment | TNK2 | 0.61 |
| 584 | Maturity-onset diabetes of the young | Enrichment | BLK | 0.59 |
| 585 | Focal segmental glomerulosclerosis | Enrichment | COL4A4 | 0.59 |
| 586 | Cardiomyopathy, dilated, 1a | Enrichment | FLNC | 0.58 |
| 587 | Hepatoblastoma | Enrichment | CTNNB1 | 0.58 |
| 588 | Myocardial infarction | Enrichment | ITGB3 | 0.56 |
| 589 | Autoinflammatory disease | Enrichment | XIAP | 0.53 |
| 590 | Muscular dystrophy | Enrichment | COL6A2 | 0.53 |
| 591 | Hydrops fetalis, nonimmune | Enrichment | HRAS | 0.50 |
| 592 | Auditory neuropathy | Enrichment | DIAPH1 | 0.50 |
| 593 | Rare genetic deafness | Enrichment | ACTG1, DIAPH1 | 0.49 |
| 594 | Hirschsprung disease 1 | Enrichment | ERBB2 | 0.46 |
| 595 | Severe covid-19 | Enrichment | ITGAV | 0.46 |
| 596 | Long qt syndrome 1 | Enrichment | CAV3 | 0.45 |
| 597 | Stargardt disease 1 | Enrichment | COL2A1 | 0.45 |
| 598 | Long qt syndrome | Enrichment | CAV3 | 0.44 |
| 599 | Non-immune hydrops fetalis | Enrichment | HRAS | 0.44 |
| 600 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | HGF, MET | 0.43 |
| 601 | Left ventricular noncompaction | Enrichment | RAF1 | 0.40 |
| 602 | Non-syndromic genetic deafness | Enrichment | ACTG1 | 0.39 |
| 603 | Epilepsy | Enrichment | DIAPH1 | 0.35 |
| 604 | Myopathy | Enrichment | COL6A2 | 0.35 |
| 605 | Charcot-marie-tooth disease | Enrichment | LAMA2 | 0.34 |
| 606 | Benign epilepsy with centrotemporal spikes | Enrichment | RELN | 0.34 |
| 607 | Congenital nervous system abnormality | Enrichment | CTNNB1, PTEN | 0.34 |
| 608 | Nervous system disease | Enrichment | CTNNB1, PTEN | 0.34 |
| 609 | Type 2 diabetes mellitus | Enrichment | AKT2 | 0.34 |
| 610 | Distal arthrogryposis | Enrichment | MYL11 | 0.34 |
| 611 | Nonsyndromic hearing loss | Enrichment | ACTG1 | 0.34 |
| 612 | Centralopathic epilepsy | Enrichment | RELN | 0.33 |
| 613 | Hypertrophic cardiomyopathy | Enrichment | MYL2 | 0.33 |
| 614 | Autism spectrum disorder | Enrichment | MAP2K1, PTEN | 0.32 |
| 615 | Sensorineural hearing loss | Enrichment | HGF | 0.30 |
| 616 | Spastic ataxia | Enrichment | FLNC | 0.27 |
| 617 | Complex neurodevelopmental disorder | Enrichment | PAK3, RAC3 | 0.27 |
| 618 | Schizophrenia | Enrichment | RELN | 0.24 |
| 619 | Cone-rod dystrophy 2 | Enrichment | ITGA4 | 0.20 |
| 620 | Hereditary retinal dystrophy | Enrichment | COL2A1, ITGA4, LAMA1 | 0.10 |
| 621 | Fundus dystrophy | Enrichment | COL2A1, ITGA4, LAMA1 | 0.10 |